Depression Treatment Market

Depression Treatment Market

A recent market study published by Future Market Insights (FMI) on the depression treatment market offers a global industry analysis for 2012-2021 and an opportunity assessment for 2022-2032. The report consists of a comprehensive assessment of the most important market dynamics.

On conducting thorough research on the historical as well as current growth parameters of the depression treatment market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the depression treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the depression treatment market in the most comprehensive way for a better understanding of readers.

Key Segments of the Depression treatment Market

Future Market Insight study on the depression treatment market offers information divided into four important segments— products, disease, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

By Products

Drugs

Selective Serotonin Reuptake Inhibitors (SSRIs)

Citalopram

Escitalopram

Fluoxetine

Fluvoxamine

Paroxetine

Sertraline

Selective Norepinephrine Reuptake Inhibitors (SNRIs)

Desvenlafaxine succinate

Duloxetine

Levomilnacipran

Venlafaxine

Bupropion

Mirtazapine

Monoamine oxidase inhibitors (MAOIs)

Phenelzine

Tranylcypromine

Antipsychotics

Lithium carbonate

Aripiprazole

Brexipiprazole

Quetiapine

Trazodone

Others

TMS Devices

rTMS Devices

dTMS Devices

By Disease

Major Depression

Persistent Depressive Disorder

Bipolar Disorder

Seasonal Affective Disorder (SAD)

Postpartum Depression

Premenstrual Dysphoric Disorder (PDD)

Situational Depression

Atypical Depression

Treatment-Resistant Depression

By Distribution Channel

Hospitals

Retail Pharmacies

Drug Stores

e-commerce

Specialty Clinics

Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

Chapter 01 – Executive Summary

The report commences with the executive summary of the depression treatment market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the depression treatment market as well as the key trends affecting the market.

Chapter 02 – Market Overview

Readers can find detailed taxonomy and product definition/scope /limitations, inclusions, and exclusions of the depression treatment market in this chapter, which helps readers, understand basic information about depression treatment.

Chapter 03 – Key Market Trends

This section highlights the key trends impacting the depression treatment market, which will help readers in understanding the current trends and their impact on market growth.

Chapter 04 – Key Success Factors

This section highlights the key success factors impacting the depression treatment market, which will help readers in understanding disease epidemiology by region, drug adoption/usage analysis, new drugs approvals and launches, key promotional strategies by market players, pipeline analysis, regulatory scenario, PESTLE analysis, Porter’s analysis and value chain analysis that is expected to create a positive impact on the growth of the depression treatment market during the forecast period.

Chapter 05 – Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the depression treatment market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the depression treatment market, which include the drivers, restraints, and opportunity analysis.

Chapter 06– COVID-19 Crisis Analysis

This section provides the current and expected impact of COVID-19 on the depression treatment market.

Chapter 07 – Global Depression Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2012–2021 and Forecast, 2022–2032

This section explains the global market demand (in value or size in US$ Mn) analysis and forecast for the depression treatment market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2021), and an incremental $ opportunity for the forecast period (2022–2032).

Chapter 08 – Global Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032, by Products

Based on products, the depression treatment market is segmented into drugs (selective serotonin reuptake inhibitors (SSRIs) {citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline}, selective norepinephrine reuptake inhibitors (SNRIs) {desvenlafaxine succinate, duloxetine, levomilnaipran, and venlafaxine}, bupropion, mirtazapine, monoamine oxidase inhibitors (MAOIs) {phenelzine and tranylcypromine}, antipsychotics {lithium carbonate, aripiprazole, brexipiiprazole, quetiapine}, trazodone and others) and TMS devices (rTMS devices, dTMS devices).

In this chapter, readers can find information about a detailed analysis of the market by different products available in the depression treatment market and their growth over the forecast period.

Chapter 09 – Global Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032, By Disease

Based on disease, the depression treatment market is segmented into major depression, persistent depressive disorder, bipolar disorder, seasonal affective disorder (SAD), postpartum depression, premenstrual dysphoric disorder (PDD), situational depression, atypical depression and treatment-resistant depression.

In this chapter, readers can find information about a detailed analysis of the market by different diseases in the depression treatment market and their growth over the forecast period.

Chapter 10 – Global Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032, by Distribution Channel

Based on the distribution channel, the depression treatment market is segmented into hospitals, retail pharmacies, drug stores, e-commerce, and speciality clinics. In this chapter, readers can find information about a detailed analysis of the market by different distribution channel available in the depression treatment market and their growth over the forecast period.

Chapter 11 – Global Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032, by Region

This chapter explains how the depression treatment market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East and Africa (MEA).

Chapter 12 – North America Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the North American depression treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product, disease, distribution channel, and country of the depression treatment market in the North American region.

Chapter 13 – Latin America Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the depression treatment market in leading countries such as Brazil, Mexico, Argentina and the rest of Latin America. Readers can find thorough information about the growth parameters based on product, disease, distribution channel, and country in the Latin America depression treatment market during 2022-2032.

Chapter 14 – Europe Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the depression treatment market based on the development of the new product and regulatory approvals in several European countries such as the U.K., Germany, Italy, France, Spain, Russia, BENELUX and the Rest of Europe are included in this chapter.

Chapter 15 – South Asia Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the depression treatment market. In addition, in this chapter, readers can find thorough information about the growth parameters of the South Asia depression treatment market growth over the forecast period.

Chapter 16 – East Asia Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia depression treatment market. In addition, in this chapter, readers can find thorough information about the growth parameters of the East Asia depression treatment market through 2031.

Chapter 17 – Oceania Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

This chapter consists of important parameters that have a huge impact on the growth of the depression treatment market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania depression treatment market.

Chapter 18 – Middle East and Africa Depression Treatment Market Analysis 2012-2021 and Forecast 2022-2032

This chapter provides information on how the depression treatment market will grow in the major countries in the MEA region, such as Turkey, GCC Countries, South

Africa and North Africa during 2022-2032.

Chapter 19 – Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the depression treatment market.

Chapter 20 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the depression treatment market including the company overview, revenue shares, strategic overview, and recent company developments.

Some of the market players featured in the report include Viatris (Mylan Pharmaceuticals Inc.), Sunovian Pharmaceuticals, AbbVie Inc. (Allergan, Inc.), Jubilant Generics Limited, Sanis Health Inc., Abbott Laboratories, Aurobindo Pharma, Torrent Pharmaceuticals, Teva Pharmaceuticals, Sun Pharmaceuticals, (Apotex Holdings, Inc.) Apotex Corporation, Alembic Pharmaceuticals Limited, Pfizer Inc., Cardinal Health, Hikma Pharmaceuticals, Zydus Lifesciences (Cadila), Cipla Ltd, Dr. Reddy's Laboratories, Merck & Co., Eli Lily & Co, GlaxoSmithKline, Takeda Pharmaceuticals, BrainsWay Ltd., Nexstim Plc., Magstim Ltd., Neuronetics, Inc., Salience TMS Neuro Solutions, MagVenture, MAG & More GmbH and Neurosoft, Ltd.

Chapter 21 – Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.

Chapter 22 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the depression treatment market.

Sources and Primary Research Splits (%)

Industry Interactions

Key Designations

C - Level Executives

Marketing Directors

Product Managers

Business Development Officers

Production Managers

Procurement Heads

Sales Executives

Stakeholder Category

Distributors

Traders

Raw Material Suppliers

Industry Experts

References Catalogue

Industry Publications

World Health Organizations (WHO)

National Institute of Health (NIH)

Factiva

Company Press Releases

Annual Reports and Investor Presentations

Research Papers

Government Websites and Publications

Company Websites,

Morningstar

World bank Data

LinkedIn

Zoom info

Salesforce